Eye mounted device for therapeutic agent release
US-12167978-B2 · Dec 17, 2024 · US
US10046065B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10046065-B2 |
| Application number | US-201414909162-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 5, 2014 |
| Priority date | Aug 6, 2013 |
| Publication date | Aug 14, 2018 |
| Grant date | Aug 14, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A nucleic acid-encapsulating polymer micelle complex is formed of a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polymer chain block; and two single-stranded DNA molecules having mutually complementary base sequences of 1000 or more bases in length, double-stranded DNA of 1000 or more base pairs in length in which at least a part of a double helix structure is dissociated and forms a single-stranded structure, or one single-stranded DNA molecule of 1000 or more bases in length.
Opening claim text (preview).
The invention claimed is: 1. A method for producing a nucleic acid-encapsulating polymer micelle complex which accommodates DNA, the method comprising: a process of mixing a block copolymer containing an uncharged hydrophilic polymer chain block and a cationic polymer chain block with double-stranded DNA of 1000 or more base pairs in a state in which at least a part of the double-stranded DNA is denatured in an aqueous medium; wherein the double-stranded DNA has been denatured at 80° C. or higher prior to the process of mixing with the block copolymer, and the complex is spherical and has diameters having a ratio of a longest diameter to another diameter of 1:1. 2. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the double-stranded DNA is 2000 or more base pairs in length. 3. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the double-stranded DNA is linear. 4. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the average particle diameter thereof in an aqueous medium measured according to a dynamic light scattering method is 100 nm or less. 5. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the DNA and the cationic polymer chain block bonded to the DNA due to an electrostatic interaction form a core portion, and the uncharged hydrophilic polymer chain block forms a shell portion. 6. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 5 , wherein the average particle diameter of the core portion is 50 nm or less. 7. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein at least a part of the block copolymer is mutually cross-linked. 8. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein a hydrophobic group is covalently bonded to a main chain or a side chain of the cationic polymer chain block. 9. The method for producing a nucleic acid-encapsulating polymer micelle complex according to claim 1 , wherein the cationic polymer chain block has an ethylamine structure or a propylamine structure in the side chain thereof.
Purification or manufacturing processes for gene therapy compositions · CPC title
Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy · CPC title
Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links · CPC title
Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence) · CPC title
Double-stranded nucleic acids or oligonucleotides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.